Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of Gastroesophageal Reflux Disease (GERD)

NCT02759094 is registered in ClinicalTrials.gov with Implantica CE Reflux Ltd. as lead sponsor.

NCT NCT02759094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02759094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of Gastroesophageal Reflux Disease (GERD)
Lead sponsor
Implantica CE Reflux Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2016
Completion date
December 31, 2023
Enrollment
50 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gerd